The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer

ConclusionTurkish oncologists participating to this trial had declared conflicting results about adjuvant treatment in early-stage colorectal cancer in their daily practice compared with the updated guidelines, especially, MSI evaluation utility in stage III colon cancers, adjuvant chemotherapy (AC) duration, and oxaliplatin adding to AC in elderly and stage II patients.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research